Noora Andersson

1.5k total citations
24 papers, 741 citations indexed

About

Noora Andersson is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Noora Andersson has authored 24 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Reproductive Medicine. Recurrent topics in Noora Andersson's work include Ovarian cancer diagnosis and treatment (7 papers), Single-cell and spatial transcriptomics (5 papers) and Cancer Genomics and Diagnostics (5 papers). Noora Andersson is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Single-cell and spatial transcriptomics (5 papers) and Cancer Genomics and Diagnostics (5 papers). Noora Andersson collaborates with scholars based in Finland, United States and United Kingdom. Noora Andersson's co-authors include Markku Heikinheimo, Mikko Anttonen, Leila Unkila‐Kallio, Ralf Bützow, Stacey Jamieson, Maria Alexiadis, Peter J. Fuller, Olli Carpén, Anniina Färkkilä and Marjut Pihlajoki and has published in prestigious journals such as Nature Communications, Bioinformatics and PLoS ONE.

In The Last Decade

Noora Andersson

24 papers receiving 738 citations

Peers

Noora Andersson
Noora Andersson
Citations per year, relative to Noora Andersson Noora Andersson (= 1×) peers Jean Michel Bidart

Countries citing papers authored by Noora Andersson

Since Specialization
Citations

This map shows the geographic impact of Noora Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noora Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noora Andersson more than expected).

Fields of papers citing papers by Noora Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noora Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noora Andersson. The network helps show where Noora Andersson may publish in the future.

Co-authorship network of co-authors of Noora Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Noora Andersson. A scholar is included among the top collaborators of Noora Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noora Andersson. Noora Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamalzadeh, Sanaz, Antti Häkkinen, Noora Andersson, et al.. (2022). QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability. Laboratory Investigation. 102(7). 753–761. 12 indexed citations
2.
Zhang, Kaiyang, Erdoğan Pekcan Erkan, Sanaz Jamalzadeh, et al.. (2022). Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Science Advances. 8(8). eabm1831–eabm1831. 93 indexed citations
3.
Mižíková, Ivana, David P. Cook, Noora Andersson, et al.. (2021). Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damage. Nature Communications. 12(1). 1565–1565. 102 indexed citations
4.
Häkkinen, Antti, Kaiyang Zhang, Amjad Alkodsi, et al.. (2021). PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples. Bioinformatics. 37(18). 2882–2888. 11 indexed citations
5.
Hukkinen, Maria, Joseph Davidson, Athanasios Tyraskis, et al.. (2021). Prognostic and Pathophysiologic Significance of IL-8 (CXCL8) in Biliary Atresia. Journal of Clinical Medicine. 10(12). 2705–2705. 17 indexed citations
6.
Kyrönlahti, Antti, Oyediran Akinrinade, Tea Soini, et al.. (2021). Evolving Up‐regulation of Biliary Fibrosis–Related Extracellular Matrix Molecules After Successful Portoenterostomy. Hepatology Communications. 5(6). 1036–1050. 11 indexed citations
7.
Cervera, Alejandra, Noora Andersson, Ville Rantanen, et al.. (2021). FUNGI: FUsioN Gene Integration toolset. Bioinformatics. 37(19). 3353–3355. 1 indexed citations
8.
Pihlajoki, Marjut, Noora Andersson, Johanna Tapper, et al.. (2020). Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors. Journal of the Endocrine Society. 4(4). bvaa034–bvaa034. 15 indexed citations
9.
Gardberg, Maria, et al.. (2019). BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas. PLoS ONE. 14(4). e0216043–e0216043. 8 indexed citations
10.
Oikkonen, Jaana, Kaiyang Zhang, Noora Andersson, et al.. (2019). Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer. JCO Precision Oncology. 3(3). 1–12. 31 indexed citations
11.
Andersson, Noora, et al.. (2018). Variation in body condition of songbirds during breeding season in relation to sex, migration strategy and weather. Ornis Fennica. 95(2). 5 indexed citations
12.
Nguyen, Elizabeth V., Kaisa Huhtinen, Young Ah Goo, et al.. (2017). Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells. Molecular & Cellular Proteomics. 16(7). 1377–1392. 20 indexed citations
13.
Andersson, Noora, Bhagwan Yadav, Anniina Färkkilä, et al.. (2017). Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells. Gynecologic Oncology. 144(3). 621–630. 27 indexed citations
14.
Andersson, Noora, Bhagwan Yadav, Evgeny Kulesskiy, et al.. (2015). Abstract 1700: Dasatinib and everolimus show synergistic growth inhibition with paclitaxel in an ovarian granulosa cell tumor model. Cancer Research. 75(15_Supplement). 1700–1700. 1 indexed citations
15.
Andersson, Noora, Mikko Anttonen, Anniina Färkkilä, et al.. (2014). Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition. Journal of Molecular Endocrinology. 52(2). 223–234. 5 indexed citations
16.
Anttonen, Mikko, Marjut Pihlajoki, Noora Andersson, et al.. (2014). FOXL2, GATA4, and SMAD3 Co-Operatively Modulate Gene Expression, Cell Viability and Apoptosis in Ovarian Granulosa Cell Tumor Cells. PLoS ONE. 9(1). e85545–e85545. 49 indexed citations
17.
Färkkilä, Anniina, Noora Andersson, Ralf Bützow, et al.. (2014). HER2 and GATA4 are new prognostic factors for early‐stage ovarian granulosa cell tumor—a long‐term follow‐up study. Cancer Medicine. 3(3). 526–536. 28 indexed citations
18.
McConechy, Melissa K., Anniina Färkkilä, Winnie Yang, et al.. (2014). Abstract 5610: Circulating tumor DNA: FOXL2 402C-G mutation can be identified in plasma from adult granulosa cell tumor patients with recurrent disease. Cancer Research. 74(19_Supplement). 5610–5610. 1 indexed citations
19.
Benayoun, Bérénice A., Adrien Georges, David L’Hôte, et al.. (2011). Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase. Human Molecular Genetics. 20(9). 1673–1686. 77 indexed citations
20.
Jamieson, Stacey, Ralf Bützow, Noora Andersson, et al.. (2010). The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Modern Pathology. 23(11). 1477–1485. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026